
Assessing adversity in immunosafety (preclinical)
The "Assessing adversity in immunosafety (preclinical)" course is 1of 18 courses in the Introduction to Immuno-Safety Science module.
This course is led by Dr. Tracey Papenfuss, DVM, PhD, DACVP; Senior Pathologist at Stagebio.
Learning Objectives
1. What does "adversity" mean in immunosafety? |
2. What factors, data, and considerations are used to determine adversity? |